E.M. IUTINSKIY, S.A. DVORYANSKIY, V.V. OVCHINNIKOV

Kirov State Medical Academy, 112 K. Marks St., Kirov, Russian Federation, 610027

Iutinskiy E.M. — Cand. Med. Sc., Associate Professor of the Department of Obstetrics and Gynecology, tel. (8332) 555-321, e-mail: dvorsa@mail.ru

Dvoryanskiy S.A. — D. Med. Sc., Head of the Department of Obstetrics and Gynecology, tel. (8332) 555-321, e-mail: dvorsa@mail.ru

Ovchinnikov V.V. — Cand. Med. Sc., Associate Professor of the Department of Obstetrics and Gynecology, tel. (8332) 555-321, e-mail: dvorsa@mail.ru

The article presents data on illnesses among children of the first year of life, born to women with fetoplacental insufficiency. A comparative assessment of efficiency of traditional pharmacological therapy of fetoplacental insufficiency and complex therapy with participation of medical ozone was carried out. In particular it is shown, that including in a complex of therapy of fetoplacental insufficiency the ozone-oxygen mixture promotes more effective elimination of hypoxia of a foetus and restoration of an adequate fetus and placental perfusion that is realised further by reduction of diseases in children of the first year of life.

Key words: pregnancy, fetoplacental insufficiency, ozone therapy.

REFERENCES 

1. Bassan H. The pregnant spontaneously hypertensive rat as a model of asymmetric intrauterine growth retardation and neurodevelopmental delay. Hypertens Pregnancy, 2013, vol. 24, no. 3, pp. 201-211.
2. Sidorova I.S., Makarov I.O. Kliniko-diagnosticheskie aspekty fetoplatsentarnoy nedostatochnosti [Clinical diagnostic aspects of placental insufficiency]. Moscow: MIA, 2005. 295 p.
3. Duttaroy A.K. Transport of fatty acids across the human placenta: a review. Prog Lipid Res., 2014, vol. 48, no. 1, pp. 52-61.
4. Hodgin J.B., Rasoulpour M., Markowitz G.S., D’Agati V.D. Very low birth weight is a risk factor for secondary focal segmental glomerulosclerosis. Clin J Am Soc Nephrol., 2012, vol. 4, no. 1, pp. 71-76.
5. Roos S., Kanai Y., Prasad P.D. et al. Regulation of placental amino acid transporter activity by mammalian target of rapamycin. Am J Physiol Cell Physiol., 2009, vol. 296, no. 1, pp. 142-150.
6. Germani D., Puglianiello A. et al. Uteroplacental insufficiency down regulates insulin receptor and affects expression of key enzymes of long-chain fatty acid (LCFA) metabolism in skeletal muscle at birth. Cardiovasc Diabetol., 2014, vol. 18, p. 14.
7. Li C.S., Loch-Caruso R. Sodium arsenite inhibits migration of extravillous trophoblast cells in vitro. Reprod Toxicol., 2014, vol. 24, no. 3-4, pp. 296-302.
8. Rees S., Inder T. Fetal and neonatal origins of altered brain development. Early Hum Dev., 2013, vol. 81, no. 9, pp. 753-761.
9. Ke X. Nonresponsiveness of cerebral p53-MDM2 functional circuit in newborn rat pups rendered IUGR via uteroplacental insufficiency. Am J Physiol Regul Integr Comp Physiol., 2014, vol. 288, no. 4, pp. 1038-1045.
10. La Marca, B.D. Pathophysiology of hypertension in response to placental ischemia during pregnancy: a central role for endothelin? Gend Med., 2012, vol. 5, rr. 133-138.